Correlation Between EnGene Holdings and Harmony Biosciences
Can any of the company-specific risk be diversified away by investing in both EnGene Holdings and Harmony Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnGene Holdings and Harmony Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between enGene Holdings Common and Harmony Biosciences Holdings, you can compare the effects of market volatilities on EnGene Holdings and Harmony Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnGene Holdings with a short position of Harmony Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnGene Holdings and Harmony Biosciences.
Diversification Opportunities for EnGene Holdings and Harmony Biosciences
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between EnGene and Harmony is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding enGene Holdings Common and Harmony Biosciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harmony Biosciences and EnGene Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enGene Holdings Common are associated (or correlated) with Harmony Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harmony Biosciences has no effect on the direction of EnGene Holdings i.e., EnGene Holdings and Harmony Biosciences go up and down completely randomly.
Pair Corralation between EnGene Holdings and Harmony Biosciences
Given the investment horizon of 90 days enGene Holdings Common is expected to under-perform the Harmony Biosciences. But the etf apears to be less risky and, when comparing its historical volatility, enGene Holdings Common is 1.66 times less risky than Harmony Biosciences. The etf trades about -0.07 of its potential returns per unit of risk. The Harmony Biosciences Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 3,575 in Harmony Biosciences Holdings on August 27, 2024 and sell it today you would lose (104.00) from holding Harmony Biosciences Holdings or give up 2.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
enGene Holdings Common vs. Harmony Biosciences Holdings
Performance |
| Timeline |
| enGene Holdings Common |
| Harmony Biosciences |
EnGene Holdings and Harmony Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with EnGene Holdings and Harmony Biosciences
The main advantage of trading using opposite EnGene Holdings and Harmony Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnGene Holdings position performs unexpectedly, Harmony Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harmony Biosciences will offset losses from the drop in Harmony Biosciences' long position.| EnGene Holdings vs. Zenas BioPharma, Common | EnGene Holdings vs. FT Vest Equity | EnGene Holdings vs. Zillow Group Class | EnGene Holdings vs. Northern Lights |
| Harmony Biosciences vs. Keros Therapeutics | Harmony Biosciences vs. Janux Therapeutics | Harmony Biosciences vs. Fennec Pharmaceuticals | Harmony Biosciences vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |